Atrial Fibrillation manifests with a spectrum of clinical presentations ranging from debilitating symptomatic episodes to silent arrhythmias detected only through screening. The cardinal complication—thromboembolic stroke—results from stasis-induced clot formation in the non-contracting left atrium, particularly the left atrial appendage. Risk stratification tools, most notably the CHA₂DS₂-VASc score, provide evidence-based frameworks for anticoagulation decisions, balancing stroke prevention against bleeding risks. Beyond thromboembolism, AF contributes significantly to heart failure progression through multiple mechanisms: irregular rapid ventricular rates increase myocardial oxygen demand, while loss of coordinated atrial contraction ("atrial kick") reduces cardiac output by up to 30% in patients dependent on this mechanism. Emerging evidence links long-standing AF with cognitive impairment and vascular dementia through mechanisms including cerebral microemboli, hypoperfusion, and altered cerebrovascular regulation. Comprehensive management requires aggressive modification of contributing factors—particularly hypertension, metabolic disorders, and sleep-disordered breathing—with recent studies demonstrating that intensive risk factor management significantly reduces AF burden, improves maintenance of sinus rhythm, and enhances long-term cardiovascular outcomes.